MarketPeel
Insider Trading Intelligence
Pricing
…
LN

Leslie V. Norwalk

CNC
DIRECTOR · CENTENE CORP · CIK 0001533568
FILING MIX · LIFETIME70%/30%
BUYS
42
SELLS
18
TOTAL VALUE
$7.33M
COMPANIES
5
ACTIVE SINCE
May 2020
HOLDINGS NOW
48,711
AVG SELL PX
$107.51
TRADE KIND
SHOWING 60 / 60
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Leslie V. Norwalk, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+62.50%-0.81%+0.47%-1.28%-1.48%—
14d8+37.50%-0.98%+0.54%-1.52%-0.29%—
30d8+50.00%-2.90%+0.88%-3.78%-4.74%—
60d8+62.50%-2.00%+1.11%-3.12%-2.00%—
90d8+62.50%+0.14%+1.58%-1.43%-1.26%—
180d8+37.50%+5.32%+9.46%-4.14%-1.74%—
1y8(4 pending)+75.00%-2.39%+14.26%-16.65%-30.47%—
2y8(4 pending)+25.00%+21.27%+37.17%-15.90%-27.74%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CNC · 1,481.005 shares · as of Mar 31, 2022
02,5005,0007,50010,000SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 42 buys / 18 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
842$139.43$117.4K2,430Jul 29, 2026Jul 30, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
842——2,140Jul 29, 2026Jul 30, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
1,250$182.01$227.5K1,588Jul 28, 2026Jul 30, 2026 ↗View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
15,527——41,572Jun 24, 2026Jun 26, 2026 ↗View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
22,714——22,714Jun 24, 2026Jun 26, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
1,250$168.06$210.1K2,838Jun 4, 2026Jun 8, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
1,284——1,284May 27, 2026May 29, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
2,624——2,624May 27, 2026May 29, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
1,659——4,088May 21, 2026May 21, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
1,659——0May 21, 2026May 21, 2026 ↗View →
CVS
CVS HEALTH CORP
PURCHASEGRANT
Stock grant
1,447$97.15$140.6K7,376May 14, 2026May 15, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
3,810$155.01$590.6K2,429May 12, 2026May 14, 2026 ↗View →
GMED
GLOBUS MEDICAL INC
PURCHASEGRANT
Stock grant
15,000——15,000Jan 21, 2026Jan 23, 2026 ↗View →
GMED
GLOBUS MEDICAL INC
SALE10b5-1
10b5-1 plan
2,000$101.10$202.2K10,419Jan 8, 2026Jan 12, 2026 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
1,190$155.09$184.6K6,239Dec 16, 2025Dec 17, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
1,724$84.95$146.5K12,429Dec 15, 2025Dec 17, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
8,276——557Dec 15, 2025Dec 17, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
1,724——0Dec 15, 2025Dec 17, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
8,276$92.35$764.3K10,705Dec 15, 2025Dec 17, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
5,000$152.23$761.1K7,429Dec 15, 2025Dec 17, 2025 ↗View →
GMED
GLOBUS MEDICAL INC
SALE10b5-1
10b5-1 plan
4,000$88.85$355.4K12,419Dec 12, 2025Dec 16, 2025 ↗View →
CVS
CVS HEALTH CORP
PURCHASEGRANT
Stock grant
1,652$76.04$125.6K5,929Nov 20, 2025Nov 21, 2025 ↗View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
16,025——26,045Jun 25, 2025Jun 27, 2025 ↗View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
23,105——23,105Jun 25, 2025Jun 27, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
1,435——2,429May 22, 2025May 22, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
1,435——0May 22, 2025May 22, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
1,659——1,659May 21, 2025May 22, 2025 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
3,305——3,305May 21, 2025May 22, 2025 ↗View →
CVS
CVS HEALTH CORP
PURCHASEGRANT
Stock grant
2,077$60.47$125.6K4,277May 15, 2025May 19, 2025 ↗View →
GMED
GLOBUS MEDICAL INC
PURCHASEGRANT
Stock grant
15,000——15,000Jan 23, 2025Mar 28, 2025 ↗View →
CVS
CVS HEALTH CORP
PURCHASEGRANT
Stock grant
2,200$57.10$125.6K2,200Nov 21, 2024Nov 22, 2024 ↗View →
GMED
GLOBUS MEDICAL INC
SALE10b5-1
10b5-1 plan
1,000$70.00$70.0K16,419Jul 11, 2024Jul 15, 2024 ↗View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
9,070——9,070May 29, 2024May 31, 2024 ↗View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
5,899——10,020May 29, 2024May 31, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
1,435——1,435May 22, 2024May 23, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
2,982——2,982May 22, 2024May 23, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
2,100——0May 17, 2024May 21, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
2,100——2,100May 17, 2024May 21, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
1,106$141.82$156.8K994May 17, 2024May 21, 2024 ↗View →
GMED
GLOBUS MEDICAL INC
SALE10b5-1
10b5-1 plan
10,590$51.99$550.6K17,419Mar 15, 2024Mar 19, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE10b5-1
10b5-1 plan
8,000$135.67$1.09M0Feb 27, 2024Feb 29, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
SALE
8,000$84.95$679.6K1,724Feb 27, 2024Feb 29, 2024 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASE
8,000$84.95$679.6K8,000Feb 27, 2024Feb 29, 2024 ↗View →
GMED
GLOBUS MEDICAL INC
PURCHASEGRANT
Stock grant
15,000——15,000Jan 26, 2024Jan 30, 2024 ↗View →
GMED
GLOBUS MEDICAL INC
PURCHASEGRANT
Stock grant
15,000——15,000Sep 1, 2023Sep 6, 2023 ↗View →
GMED
GLOBUS MEDICAL INC
PURCHASEGRANT
Stock grant
25,688——28,009Sep 1, 2023Sep 6, 2023 ↗View →
GMED
GLOBUS MEDICAL INC
PURCHASEGRANT
Stock grant
2,321——2,321Sep 1, 2023Sep 6, 2023 ↗View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
12,787——12,787Jun 15, 2023Jun 20, 2023 ↗View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
4,121——4,121Jun 15, 2023Jun 20, 2023 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
4,290——4,290May 17, 2023May 19, 2023 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
2,100——2,100May 17, 2023May 19, 2023 ↗View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
10,192——10,192Jun 16, 2022Jun 21, 2022 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
9,724——9,724May 18, 2022May 20, 2022 ↗View →
CNC
CENTENE CORP
PURCHASEGRANT
Stock grant
381.005$82.02$31.3K1,481.005Mar 31, 2022Apr 4, 2022 ↗View →
CNC
CENTENE CORP
PURCHASEGRANT
Stock grant
1,100——1,100Feb 7, 2022Feb 9, 2022 ↗View →
CNC
CENTENE CORP
PURCHASEGRANT
Stock grant
10,000——10,000Feb 7, 2022Feb 9, 2022 ↗View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
7,511——7,511Jun 8, 2021Jun 10, 2021 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
8,833——8,833May 19, 2021May 20, 2021 ↗View →
ARVN
ARVINAS, INC.
PURCHASEGRANT
Stock grant
12,000——12,000Jun 3, 2020Jun 4, 2020 ↗View →
NBIX
NEUROCRINE BIOSCIENCES INC
PURCHASEGRANT
Stock grant
6,018——6,018May 19, 2020May 21, 2020 ↗View →
Other insiders · CNC
Loading peer insiders…
About this filer
CIK 0001533568
ROLE
Director
PRIMARY
CNC
COMPANIES
5
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001533568DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback